- First approved allogeneic cell therapy product globally for the treatment of CLI
- Developed by Stempeutics over a period of twelve years, breakthrough treatment designed to address root cause of the disease at an affordable cost
- Cipla to market and distribute the drug in India to provide patient access
 |
MUMBAI, India, Aug. 21, 2020 /PRNewswire/...
Medow Health AI ip in another $3.5M into AI medtech capital raise Medow Health AI, the Australian health-tech company buildin...
Walk through many Australian shopping strips and there is a contradiction in plain sight. Australians are spending more mo...
Australia's reporting season delivered uneven results, sharp share price reactions and a more cautious outlook from many li...
The iPhone 18 Pro Max can cost more than many people would spend on a computer. Its appeal says as...
The Australian-born fitness brand is bringing its global competition home, with athletes from across...
Spring is here, and it's arrived warm. Sydney recorded temperatures more typical of midsummer in t...
Every Australian family with school-aged children knows the pattern. Look at an airfare, hotel ro...
Spring is here, and it's arrived warm. Sydney recorded temperatures more typical of midsummer in t...
New social and nature prescribing hubs connect locals to community activities to combat loneliness...
Medical experts issue an urgent wake-up call for Women’s Health Week, revealing how everyday delay t...